Cleveland Clinic will expand its use of the IBM Watson supercomputer, using a newer Genomics Analytics cloud service to help oncologists deliver personalized treatment to cancer patients.

The clinic was an early adopter of Watson technology, working with IBM to develop a new process to train the supercomputer to interact with clinicians in a more natural way, and to improve clinical decision support.

Now, the clinic will test using Watson to aid in identifying patterns in genome sequencing and medical data, as well as review massive databases of medical journals, to support personalized treatment plans for individuals suffering from a variety of cancers.

The goal is to have care options tailored to an individual’s DNA, which can significantly improve the effectiveness of treatment. Watson continually learns as information from journals and other medical content, as well as new patient scenarios, are entered into the application.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access